Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Genpact (G) Shares Outstanding (2016 - 2026)

Genpact has reported Shares Outstanding over the past 17 years, most recently at $170.3 million for Q4 2025.

  • For Q4 2025, Shares Outstanding fell 2.47% year-over-year to $170.3 million; the TTM value through Dec 2025 reached $170.3 million, down 2.47%, while the annual FY2025 figure was $170.3 million, 2.47% down from the prior year.
  • Shares Outstanding for Q4 2025 was $170.3 million at Genpact, down from $172.4 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $188.1 million in Q3 2021 and troughed at $170.3 million in Q4 2025.
  • A 5-year average of $180.5 million and a median of $181.4 million in 2023 define the central range for Shares Outstanding.
  • Biggest five-year swings in Shares Outstanding: dropped 0.73% in 2023 and later decreased 2.84% in 2025.
  • Year by year, Shares Outstanding stood at $185.3 million in 2021, then decreased by 1.3% to $182.9 million in 2022, then fell by 1.88% to $179.5 million in 2023, then dropped by 2.69% to $174.7 million in 2024, then fell by 2.47% to $170.3 million in 2025.
  • Business Quant data shows Shares Outstanding for G at $170.3 million in Q4 2025, $172.4 million in Q3 2025, and $174.3 million in Q2 2025.